Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897948 · ClinicalTrials.gov registry record · NA
The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children
A NA study, sponsored by Mead Johnson Nutrition.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01897948: Clinical Trial NA study, sponsored by Mead Johnson Nutrition.
NCT01897948 is a NA study that was terminated before completion, run by Mead Johnson Nutrition. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01897948, a NA study, was terminated before completion, sponsored by Mead Johnson Nutrition.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This clinical trial will measure Docosahexaenic Acid (DHA) levels in the blood and evaluate the relation to cognitive outcomes.
Interventions
- OTHER Milk-based beverage without DHA
- OTHER Milk-based beverage with DHA at mid level
- OTHER Milk-based beverage with DHA at high level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Why NCT01897948 stopped before completion
NCT01897948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Milk-based beverage without DHA is the first listed.
NCT01897948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01897948 about?
NCT01897948 is a clinical study titled "The Effects of Feeding Different Levels of Docosahexaenoic Acid to Pre-School Children". This clinical trial will measure Docosahexaenic Acid (DHA) levels in the blood and evaluate the relation to cognitive outcomes.
What is the current status of trial NCT01897948?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2013-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01897948?
The interventions under investigation include: Milk-based beverage without DHA (OTHER), Milk-based beverage with DHA at mid level (OTHER), Milk-based beverage with DHA at high level (OTHER).
Who is sponsoring clinical trial NCT01897948?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01897948's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia